Results 1 to 10 of about 1,834 (149)
Effect of dipeptidyl peptidase-4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus. [PDF]
J Diabetes, 2023 Highlights Preclinical data showed that dipeptidyl peptidase‐4 inhibitors (DPP‐4is) may prevent insulin‐induced atherosclerosis. In patients treated with insulin for type 2 diabetes who underwent ≥2 serial coronary computed tomography angiographies(CCTA), a new obstructive coronary artery disease (OCAD) was less developed on the follow‐up CCTA in those
Choi Y, Ko SH, Chang K, Yoo KD, Ihm SH.
europepmc +2 more sources
Journal of Diabetes, Volume 15, Issue 7, Page 557-568, July 2023., 2023 Highlights The association between stress hyperglycemia ratio (SHR) and long‐term outcomes was still controversial. Based on a large prospective multicenter cohort, we found that high SHR levels were independently associated with increased risk of major adverse cardiovascular events (MACE), all‐cause death, and unplanned revascularization. Associations
Guyu Zeng +18 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 8, Page 524-531, August 2022., 2022 Highlights In this ESCAPE‐extension study, cilostazol treatment reduced the incidence of adverse cardiovascular events in patients with type 2 diabetes when compared with aspirin for a 5.2‐year median follow‐up. During the follow‐up period, no adverse events were noted in the cilostazol group that exceeded those in the aspirin group.
Minji Sohn, Eun Ju Chun, Soo Lim
wiley +1 more source
Journal of Diabetes, Volume 13, Issue 8, Page 640-647, August 2021., 2021 Highlights A nested, nationwide, propensity‐matched cohort study was carried out using the Clinical Practice Research Datalink with 1186 patients with no past history of ASCVD, half of whom had undergone bariatric surgery. Bariatric surgery was associated with improved ASCVD outcomes and lower mortality, highlighting a potential prognostic role of the ...
Maddalena Ardissino +6 more
wiley +1 more source
Journal of Diabetes, Volume 12, Issue 3, Page 247-258, March 2020., 2020 Highlights The GRK2 level elevated not only in the myocardium of diabetic mice with early stage of diabetic cardiomyopathy but also in the peripheral blood mononuclear cells of type 2 diabetic patients with the early stage of diabetic cardiomyopathy. The study findings suggested that the GRK2 was a potential biomarker for early diabetic cardiomyopathy.
Shuiqing Lai +6 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2021 冠状动脉粥样硬化性心脏病指冠状动脉发生粥样硬化引起管腔狭窄或闭塞,导致心肌缺血、缺氧或坏死而引起的心脏病,简称冠心病(CHD)。随着我国经济和社会水平提高,老龄化日益严重,其发病率也在逐年提升,因此研究动脉粥样硬化机制,寻找有效的治疗手段尤为重要。近年来,人们逐渐认识到心外膜脂肪组织(EAT)在冠状动脉疾病(CAD)的发生、发展和预后中的重要作用[1]。现就EAT对冠状动脉影响研究进展进行综述。
吴熙, 张明, 张建奇, 张基昌
doaj
Zhongguo shiyan zhenduanxue, 2021 心肺运动试验（CPET）作为一种全面、客观、无创的检测手段,在冠心病（至少一支主要冠状动脉或其主要分支内径狭窄≥50%）的诊断、严重程度、疗效评价及预后康复方面的作用已得到广泛认可[1-3]。本研究通过分析50例冠状动脉微血管病变（CMD）患者CPET相应指标,为冠状动脉微血管疾病诊断提供依据。
王彦新, 耿祯, 刘振华
doaj
Huli yanjiu, 2016 摘要： 冠状动脉疾病发病率的逐渐上升使冠状动脉疾病成为一项公共卫生问题，其临床诊断与治疗引起了人们的广泛关注。CTA技术以其无创、经济、直观的成像效果逐渐成为冠状动脉疾病的主要检查及诊断方法,甚至在不久的将来可替代诊断性的冠状动脉造影。完善而优质的护理干预是保障医疗辅助检查效果的关键，系统的心理护理则能为冠状动脉CTA检查效果保驾护航。
史金雁, 王巧红, 柴云花
doaj
Zhongguo shiyan zhenduanxue, 2012 冠状动脉粥样硬化性心脏病（冠心病）是当今社会死亡率最高的疾病之一,如何能更广泛而简便的诊断,一种无创冠状动脉检查—冠状动脉CT血管成像（coronary CT angiography,CCTA）作越发显得重要 ...
刁晓艳, 王波
doaj
Zhongguo shiyan zhenduanxue, 2015 冠状动脉粥样硬化性心脏病简称冠心病（CHD）,是一种常见病、多发病,为当今社会人类常见的死亡原因之一,并且其发病成逐年增高趋势。近年来,心脑血管疾病年轻化的趋势,对其早发现、早诊断、早治疗显得尤为重要,目前对CHD的诊断如:冠状动脉血管内超声（IVUS）,冠状动脉CTA以及检测冠心病的"金标准"冠状动脉造影（CAG）,这些检查存在着检测费用高、仪器价格昂贵 ...
杨建涛, 张继文
doaj